Our team focuses on research in cancer in older adults (geriatric oncology). The major diseases we study are prostate cancer and acute myeloid leukaemia (AML). Our major projects include:
1) Examining the impact of androgen deprivation therapy (hormone therapy) on health outcomes (including quality of life, physical function, cognitive function and bone health).
2) Examining quality of life and cancer-related fatigue in younger and older patients with AML from diagnosis through 3 years of follow-up.
3) Clinical trials examining the role of exercise in AML survivors, AML patients receiving active chemotherapy and men with prostate cancer on androgen deprivation therapy to improve quality of life, fatigue, physical fitness and treatment tolerability.
4) A clinical trial and knowledge translation project examining ways to improve bone health care in men with prostate cancer on androgen deprivation therapy.
5) Understanding the value of geriatric assessment in older patients with cancer.
6) Looking at short-term toxicities of treatment of prostate cancer as a function of age, comorbidity and other factors.
7) Looking at population-based treatment and outcome patterns in patients with AML.
8) Dr. Alibhai's graduate students are examining a variety of cancer-related issues, including the role of active surveillance in men with prostate cancer, the link between diabetes and prostate cancer, the impact of androgen deprivation therapy on self-reported cognitive function in men with prostate cancer and the value of palliative care in people with pancreatic cancer in Ontario.
- Staff Physician, Division of General Internal Medicine and Geriatrics, Mount Sinai Hospital
- Associate Professor, Department of Medicine, the Institute of Health Policy, Management, and Evaluation, and the Institute of Medical Sciences, University of Toronto
- Research Scientist, Canadian Cancer Society